Chemoradiation after surgery for high-risk head and neck cancer patients: How strong is the evidence?

Oncologist

Volumn 10, Issue 3, 2005, Pages 215-224

  Bernier, Jacques ^a   Cooper, Jay S ^b  

^a SAN GIOVANNI HOSPITAL   (Switzerland)

^b MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

Chemoradiation; Chemotherapy; Head and neck; Radiotherapy; Squamous cell carcinoma; Surgery

Indexed keywords

CETUXIMAB; CISPLATIN; FLUOROURACIL;

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; EUROPE; EVIDENCE BASED MEDICINE; HEAD AND NECK CANCER; HIGH RISK POPULATION; HUMAN; LYMPH NODE METASTASIS; PATIENT SELECTION; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; REVIEW; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED STATES;

CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; EVIDENCE-BASED MEDICINE; HEAD AND NECK NEOPLASMS; HUMANS; PATIENT SELECTION; RADIOTHERAPY, ADJUVANT; RISK FACTORS; TREATMENT OUTCOME;

EID: 16244371725     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.10-3-215     Document Type: Review

References (61)

1. Laramore GE, Scott CB, al-Sarraf M et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys 1992;23:705-713.
2. Stell PM, Rawson NS. Adjuvant chemotherapy in head and neck cancer. Br J Cancer 1990;61:779-787.
3. Munro AJ. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 1995;71:83-91.
4. El-Sayed S, Nelson N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials. J Clin Oncol 1996;14:838-847.
5. Pignon JP, Bourhis J, Domenge C et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000;355:949-955.
6. Browman GP, Hodson DI, Mackenzie RJ et al. Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: a systematic review of the published literature with subgroup analysis. Head Neck 2001;23:579-589.
7. Leibel SA, Scott CB, Mohiuddin M et al. The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: results of an analysis from the RTOG Head and Neck Database. J Radiat Oncol Biol Phys 1991;21:549-556.
8. Weissberg J, Son Y, Papac R. Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer. Int J Radiat Oncol Biol Phys 1989;17:3-9.
9. Bachaud JM, David JM, Boussin G et al. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: preliminary report of a randomized trial. Int J Radiat Oncol Biol Phys 1991;20:243-246.
10. Weissler M, Melin S, Sailer S et al. Simultaneous chemoradiation in the treatment of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1992;118:806-810.
11. Haffty B, Son Y, Sasaki C et al. Mitomycin C as an adjunct to post-operative radiation therapy in squamous cell carcinoma of the head and neck: results from two randomized clinical trials. Int J Radiat Oncol Biol Phys 1993;27:241-250.
12. Bachaud JM, Cohen-Jonathan E, Alzieu C et al. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. Int J Radiat Oncol Biol Phys 1996;36:999-1004.
13. Bernier J, Domenge C, Ozsahin M et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004;350:1945-1952.
14. Cooper JS, Pajak TF, Forastiere AA et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350;19:1937-1944.
15. Fletcher GH, Evers W. Radiotherapeutic management of surgical recurrences and postoperative residuals in tumors of the head and neck. Radiology 1970;95:185-188.
16. Kramer S, Gelber RD, Snow JB et al. Combined radiation therapy and surgery in the management of head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg 1987;10:19-30.
17. Snow GB, Annyas AA, van Slooten EA et al. Prognostic factors of neck node metastases. Clin Otolaryngol 1982;7:185-192.
18. Vikram B, Strong EW, Shah JP et al. Failure at the primary site following multimodality treatment in advanced head and neck cancer. Head Neck Surg 1984;6:720-723.
19. Johnson JT, Barnes EL, Myers EN et al. The extracapsular spread of tumors in cervical node metastasis. Arch Otolaryngol 1981;107:725-729.
20. Barkley HT Jr, Fletcher GH, Jesse RH et al. Management of cervical lymph node metastases in squamous cell carcinomas of the tonsillar fossa, base of tongue, supraglottic larynx and hypopharynx. Am J Surg 1972;124:462-467.
21. Bitter K. Postoperative chemotherapy versus postoperative cobalt-60 radiation therapy in patients with advanced oral carcinoma. Head Neck Surg 1981;3:260.
22. Shah JT, Cendon AA, Farr HW et al. Carcinoma of the oral cavity: factors affecting treatment failure at the primary site and neck. Am J Surg 1976;132:504-507.
23. Bartelink H, Breur K, Hart G. Radiotherapy of lymph node metastases in squamous cell carcinomas of the head and neck region. Int J Radiat Oncol Biol Phys 1982;8:983-990.
24. Bataini JP, Asselain B, Jaulerry C et al. A multivariate primary tumor control analysis in 465 patients treated by radical radiotherapy for carcinoma of the tonsillar region: clinical and treatment parameters as prognostic factors. Radiother Oncol 1989;14:265-277.
25. Bernier J, Bataini JP. Regional outcome in oropharyngeal and pharyngolaryngeal cancers treated with high dose per fraction radiotherapy. Analysis of neck disease response in 1646 cases. Radiother Oncol 1986;6:87-103.
26. Griffin TW, Pajak TF, Gillespie BW et al. Predicting the response of head and neck cancers to radiation therapy with a multivariate modelling system: an analysis of the RTOG head and neck cancer registry. Int J Radiat Oncol Biol Phys 1984;10:481-487.
27. Peters LJ, Goepfert H, Ang KK et al. Evaluation of the dose for post-operative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 1993;26:3-11.
28. Cooper JS, Pajak TF, Forastiere AA et al. Precisely defining high-risk operable head and neck tumors based on RTOG#85-03 and RTOG#88-24: targets for postoperative chemoradiotherapy? Head Neck 1998;20:588-594.
29. Al-Sarraf M, Pajak TF, Byhardt RW et al. Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24. Int J Radiat Oncol Biol Phys 1997;37:777-782.
30. Jacobs J, Ahmad K, Casiano R et al. Implications of positive surgical margins. Laryngoscope 1993;103:64-68.
31. Laramore GE, Scott CB, Schuller DE et al. Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell carcinoma of the head and neck: a comparative study using the intergroup study 0034 and the Radiation Therapy Oncology Group head and neck database. J Radiat Oncol Biol Phys 1993;27:1011-1016.
32. Ang KK, Trotti A. Brown BW et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;51:571-578.
33. Sanguineti G, Corvo R, Vitale V et al. Postoperative radiotherapy for head and neck squamous cell carcinomas: feasibility of a biphasic accelerated treatment schedule. Int J Radiat Oncol Biol Phys 1996;36:1147-1153.
34. Trotti A, Klotch D, Endicott J et al. Postoperative accelerated radiotherapy in high-risk squamous cell carcinoma of the head and neck: long-term results of a prospective trial. Head Neck 1998;20:119-123.
35. Bernier J, Bentzen SM. Head and neck cancer management: which postoperative treatment best serves your patient? ASCO 2003 Educational Book, 306-312.
36. Dewit L. Combined treatment of radiation and cisdiamminedichloroplatinum (II): a review of experimental and clinical data. Int J Radiat Oncol Biol Phys 1987;13:403-426.
37. Fu KK, Phillips TL, Silverberg IY et al. Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancers: update of a Northern California Oncology Group randomized trial. J Clin Oncol 1987;5:1410-1418.
38. Tannock IF. Combined modality treatment with radiotherapy and chemotherapy. Radiother Oncol 1989;16:83-101.
39. Huang AT, Cole TB, Fishburn R et al. Adjuvant chemotherapy after surgery and radiation for stage III and IV head and neck cancer. Ann Surg 1984;200:195-199.
40. Jacobs JR, Pajak TF, Al-Sarraf M et al. Chemotherapy following surgery in head and neck cancer. A Radiation Therapy Oncology Group study. Am J Clin Oncol 1989;12:185-189.
41. Johnson JT, Myers EN, Schramm VL et al. Adjuvant chemotherapy for high risk squamous cell carcinomas of the head and neck. J Clin Oncol 1987;5:456-458.
42. Rossi A, Molinari R, Boracchi P et al. Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a four-year multicenter randomized study. J Clin Oncol 1988;6:1401-1410.
43. Vokes EE, Awan AM, Weichselbaum RR. Radiotherapy with concomitant chemotherapy for head and neck cancer. Oncol Clin North Am 1991;5:753-767.
44. Begg AC. Cisplatin and radiation: interaction probabilities and therapeutic possibilities. Int J Radiat Oncol Biol Phys 1990;19:1183-1189.
45. Creagan ET, Fountain KS, Frytak S et al. Concomitant radiation therapy and cis-diamminedichloroplatinum (II) in patients with advanced head and neck cancer. Med Pediatr Oncol 1981;9:119-120.
46. Denham JW, Abbott RL. Concurrent cisplatin, infusional 5-fluorouracil, and conventionally fractionated radiation therapy in head and neck cancer: dose-limiting mucosal toxicity. J Clin Oncol 1991;9:458-463.
47. Leipzig B. Cisplatin sensitization to radiotherapy of squamous cell carcinomas of the head and neck. Am J Surg 1983;146:462-465.
48. Brizel DM, Albers ME, Fisher SR et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998;338:1798-1804.
49. Dobrowsky W, Naude J, Widder J et al. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers. Int J Radiat Oncol Biol Phys 1998;42:803-806.
50. Calais G, Alfonsi M, Bardet E et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Nat Cancer Inst 1999;91:2081-2086.
51. Jeremic C, Shibamoto Y, Milicic B et al. Hyperfractionated radiotherapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol 2000;18:1458-1464.
52. Adelstein D, Lavertu P, Saxton J et al. Mature results of a phase HI randomized trial comparing concurrent chemoradiotherapy with radiation alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 2000;88:876-883.
53. Staar S, Rudat V, Stuetzer H et al. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy: results of a multicentric randomized German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;50:1161-1171.
54. Adelstein D, Li Y, Adams G et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patient with unresectable squamous cell head and neck cancer J Clin Oncol 2003;21:92-98.
55. Denis F, Garaud P, Bardet E et al. Final results of the 94-01 GORTEC randomized trial comparing radiotherapy alone to concomitant radiochemotherapy in advanced stage oropharynx carcinoma. J Clin Oncol 2004;22:69-76.
56. Bourhis J, Amand C, Pignon JP et al. Update of MACH-NC (meta-analysis of chemotherapy in head & neck cancer) database focused on concomitant chemoradiotherapy. Proc Am Soc Clin Oncol 2004;22:489s.
57. Szpirglas H, Chastang CL, Bertrand JC. Adjuvant treatment of tongue and floor of mouth cancer. Recent Results Cancer Res 1978;68:309-317.
58. Bieri S, Bentzen SM, Huguenin P et al. Early morbidity after radiotherapy with or without chemotherapy in advanced head and neck cancer. Experience from four nonrandomized studies. Strahlenther Onkol 2003;179:390-395.
59. Trotti A, Bentzen SM. The need for adverse effects reporting standards in oncology clinical trials. J Clin Oncol 2004;22:19-22.
60. Smid L, Budihna M, Zakotnik B et al. Postoperative concomitant irradiation and chemotherapy with mitomycin C and bleomycin for advanced head-and-neck carcinoma. Int J Radiat Oncol Biol Phys 2003;56:1055-1062.
61. Bonner JA, Giralt J, Hirari PM et al. Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of head and neck: a phase III study of high dose radiation therapy with or without cetuximab. Proc Am Soc Clin Oncol 2004;22:5507.